Results 21 to 30 of about 67,462 (301)

Relationship between device acceptance and patient-reported outcomes in left ventricular assist device (LVAD) recipients [PDF]

, 2019
The number of Left Ventricular Assist Devices (LVADs) implanted each year is rising. Nevertheless, there are minimal data on device acceptance after LVAD implant, and on its relationship with patient-reported outcomes. We designed a cross-sectional study
Adamo, Luigi, Carney, Robert M., Clemenza, Francesco, Craddock, Heidi, Di Blasi, Maria, Ewald, Gregory, Girgenti, Rosario, Tosto, Crispino   +7 more
core   +2 more sources

Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure : analysis of the British NHS Bridge to Transplant (BTT) program [PDF]

, 2001
Background: A previous cost-effectiveness analysis showed that bridge to transplant (BTT) with early design left ventricular assist devices (LVADs) for advanced heart failure was more expensive than medical management while appearing less beneficial ...
Aileen Clarke, Ruth Pulikottil-Jacob, Martin Connock, Gaurav Suri, Ngianga-Bakwin Kandala, Hendramoorthy Maheswaran, Nicholas R. Banner, Paul Sutcliffe, Aaronson, Garber, Weinstein, Slaughter, Temple, MacGowan, Clegg, Clegg, Sharples, Sharples, Sharples, Slaughter, Sharples, National Institute for Health and Clinical Excellence, Gohler, Rogers, Personal social services research unit, Briggs, Levy, Schaffer, Strueber, Rose, Stevenson, National Institute for Health and Clinical Excellence, Moreno, Pagani   +33 more
core   +11 more sources

Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non–Left Ventricular Assist Device Centers

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Cardiogenic shock (CS) is a complex syndrome associated with high morbidity and mortality. In recent years, many US hospitals have formed multidisciplinary shock teams capable of rapid diagnosis and triage. Because of preexisting collaborative
Joseph I. Wang, Daniel Y. Lu, MHS, Dmitriy N. Feldman, Stephen A. McCullough, Parag Goyal, Maria G. Karas, Irina Sobol, Evelyn M. Horn, Luke K. Kim, Udhay Krishnan   +10 more
doaj   +1 more source

Implications of Transitional Care Interventions on Hospital Readmissions in Patients With Destination Therapy Left Ventricular Assist Devices [PDF]

, 2019
Background: The rising number of patients with a left ventricular assist device (LVAD) require care management to successfully transition home after implantation. These patients and their families need to manage their heart failure, and the complexities
Hirschman, Karen, Iseler, Jackeline I., Shaid, Elizabeth C., Wierenga, Kelly L.   +3 more
core   +1 more source

Optimal timing of heart transplantation in patients with an implantable left ventricular assist device

Korean Journal of Transplantation, 2023
Heart transplantation (HTPL) has been established as the gold-standard surgical treatment for end-stage heart failure. However, the use of a left ventricular assist device (LVAD) as a bridge to HTPL has been increasing due to the limited availability of ...
Suk Ho Sohn, Yoonjin Kang, Ho Young Hwang, Hyun Keun Chee   +3 more
doaj   +1 more source

A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients [PDF]

, 2014
BACKGROUND: Thrombotic events are a common complication of left ventricular assist device placement and warrant prophylactic anticoagulation. Heparin is the most common anticoagulant used for prophylaxis of thrombotic events in left ventricular assist ...
Aesha Shah, Nicholas Tillman, Scott T Benken, Suhuir Dajani, Toby Thomas   +4 more
core   +1 more source

Hybrid closure of ventricular septal defect and implantation of systemic right ventricular assist device

ESC Heart Failure, 2022
A 50‐year‐old female patient was readmitted with refractory systemic right ventricular failure. The patient underwent a Mustard procedure during childhood for transposition of the great arteries.
Jerome Soquet, Ali Houeijeh, Marjorie Richardson, Eleonore Hebbar, Guy Vaksmann, Jean‐Benoit Baudelet, Mouhamed Djahoum Moussa, Andre Vincentelli   +7 more
doaj   +1 more source

Left Ventricular Assist Device (LVAD) Implantation and Renal Dysfunction [PDF]

Ķazaķstannyṇ Klinikalyķ Medicinasy, 2018
Pathophysiological, pathomorphological and functional changes in the kidneys after left ventricular assist device implantation have not yet been fully understood and represent an actual problem of our time.
Assem Nogaibayeva, Bagdat Sultanova, Myrzabek Makhmutov   +2 more
doaj   +1 more source

Understanding Left Ventricular Assist Devices

Blood Purification, 2018
<b><i>Background/Aims:</i></b> Long-term mechanical assist devices are now commonly used in the treatment of severe heart failure to unload the failing ventricle, maintain sufficient end-organ perfusion and improve functional capacity.
Aissaoui, Nadia (Dr. rer. nat.), Jouan, Jerome, Gourjault, Melissa, Diebold, Benoit (Prof. Dr.), Ortuno, Sofia, Hamdan, Amer, Latremouille, Christian (Prof. Dr. med.), Pirracchio, Romain (Prof. Dr. med.), Morshuis, Michiel (Dr. med.)   +8 more
openaire   +3 more sources

Methodological Study of Reliability Test of Percutaneous Ventricular Assist Device

Zhongguo yiliao qixie zazhi
Prior to clinical application, reliability of percutaneous ventricular assist devices(pVAD) requires to be tested systematically. Currently, there's a lack of dedicated reliability testing equipment and methodologies for pVAD.
Xun LIU, Da ZHU, Yujing ZHANG, Xiangbin PAN   +3 more
doaj   +1 more source